Corbus Pharmaceuticals Holdings, Inc. CRBP
7.14
(0.31)
(4.16%)
as of 25 Sep
- Market cap
- $144.1M
- P/E
- 0.0×
Follow CRBP
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (95.58%) | (66.70%) | (54.18%) | (55.65%) |
+8 more TTM periods Free account |
|
| (80.85%) | (59.44%) | (48.47%) | (49.34%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(100.55%) | (67.33%) | (53.64%) | (74.42%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(4.47) | (3.94) | (4.84) | (4.84) | |
Free Cash Flow |
(86.69) | (73.65) | (64.49) | (59.51) | |
Capital Expenditures |
(0.02) | (0.01) | 0.00 | — | |
| Other line items | |||||
Cash ROIC |
(39.36%) | (27.79%) | (20.71%) | (30.30%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.85 | 0.87 | 0.82 | 0.88 | |
Depreciation/Fixed assets |
(15.70) | (11.27) | (7.13) | (5.89) | |
Capex/Depreciation |
0.02 | 0.01 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.47) | (3.94) | (4.84) | (4.84) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates